Marizyme, Inc. Strengthens Senior Management Team with Two Appointments: Roger Schaller EVP, Commercial Operations and Amy Chandler, EVP, Regulatory Affairs and Quality Management Systems

Company Focuses on Commercial Development, Revenue Generation and Operating Excellence JUPITER, Fla., Feb. 1, 2021 -- (Healthcare Sales & Marketing Network) -- Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing produ... Devices, Cardiology, Surgery, Personnel Marizyme, DuraGraft, vascular graft, CABG
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news